North Star Investment Management Corp. Altimmune, Inc. Transaction History
North Star Investment Management Corp.
- $1.41 Billion
- Q2 2025
A detailed history of North Star Investment Management Corp. transactions in Altimmune, Inc. stock. As of the latest transaction made, North Star Investment Management Corp. holds 17,000 shares of ALT stock, worth $61,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,000
Previous 30,000
43.33%
Holding current value
$61,540
Previous $150,000
56.67%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ALT
# of Institutions
213Shares Held
38.1MCall Options Held
2.28MPut Options Held
1.83M-
Black Rock Inc. New York, NY5.32MShares$19.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$18.7 Million0.0% of portfolio
-
State Street Corp Boston, MA2.75MShares$9.97 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$9.96 Million0.89% of portfolio
-
Geode Capital Management, LLC Boston, MA1.93MShares$7 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $177M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...